世界の筋骨格系障害治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Musculoskeletal Disorders Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QYR2104Z3974 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、132ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥553,800 (USD3,900)	▷ お問い合わせ
Multi User/Five User	￥830,700 (USD5,850)	▷ お問い合わせ
Enterprise License（同一法人内共有可）	￥1,107,600 (USD7,800)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査資料では、筋骨格系障害治療のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（生物製剤、小分子）、用途別市場規模（変形性関節症、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・筋骨格系障害治療の市場動向 ・企業の競争状況、市場シェア ・筋骨格系障害治療の種類別市場規模（生物製剤、小分子） ・筋骨格系障害治療の用途別市場規模（変形性関節症、骨粗鬆症、乾癬性関節炎、強直性脊椎炎、線維筋痛症） ・筋骨格系障害治療の北米市場規模2016-2027（アメリカ、カナダ） ・筋骨格系障害治療のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・筋骨格系障害治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・筋骨格系障害治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・筋骨格系障害治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AbbVie、Johnson & Johnson、Amgen、Pfizer、F. Hoffmann-La Roche、Eli Lilly、Merck、Novartis、AstraZeneca、Astellas、AB Sciences、3SBio、Samsung Bioepis、Sanofi、Taisho Pharmaceutical、Takeda、Zosano Pharma、LG Life Sciences） ・結論

Market Analysis and Insights: Global Musculoskeletal Disorders Therapeutics Market
The global Musculoskeletal Disorders Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Musculoskeletal Disorders Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Musculoskeletal Disorders Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Musculoskeletal Disorders Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Musculoskeletal Disorders Therapeutics market.

Global Musculoskeletal Disorders Therapeutics Scope and Market Size
Musculoskeletal Disorders Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Musculoskeletal Disorders Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Biologics
Small Molecules

Segment by Application
Osteoarthritis
Osteoporosis
Psoriatic Arthritis
Ankylosing Spondylitis
Fibromyalgia

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AbbVie
Johnson & Johnson
Amgen
Pfizer
F. Hoffmann-La Roche
Eli Lilly
Merck
Novartis
AstraZeneca
Pfizer
F. Hoffmann-La Roche
3SBio
Samsung Bioepis
Sanofi
Taisho Pharmaceutical
Takeda

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Biologics
1.2.3 Small Molecules
1.3 Market by Application
1.3.1 Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Osteoarthritis
1.3.3 Osteoporosis
1.3.4 Psoriatic Arthritis
1.3.5 Ankylosing Spondylitis
1.3.6 Fibromyalgia
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Musculoskeletal Disorders Therapeutics Market Perspective (2016-2027)
2.2 Musculoskeletal Disorders Therapeutics Growth Trends by Regions
2.2.1 Musculoskeletal Disorders Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Musculoskeletal Disorders Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Musculoskeletal Disorders Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Musculoskeletal Disorders Therapeutics Industry Dynamic
2.3.1 Musculoskeletal Disorders Therapeutics Market Trends
2.3.2 Musculoskeletal Disorders Therapeutics Market Drivers
2.3.3 Musculoskeletal Disorders Therapeutics Market Challenges
2.3.4 Musculoskeletal Disorders Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue
3.1.1 Global Top Musculoskeletal Disorders Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Musculoskeletal Disorders Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Musculoskeletal Disorders Therapeutics Revenue
3.4 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio
3.4.1 Global Musculoskeletal Disorders Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Musculoskeletal Disorders Therapeutics Revenue in 2020
3.5 Musculoskeletal Disorders Therapeutics Key Players Head office and Area Served
3.6 Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
3.7 Date of Enter into Musculoskeletal Disorders Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Musculoskeletal Disorders Therapeutics Breakdown Data by Type
4.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2022-2027)

5 Musculoskeletal Disorders Therapeutics Breakdown Data by Application
5.1 Global Musculoskeletal Disorders Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Musculoskeletal Disorders Therapeutics Market Size (2016-2027)
6.2 North America Musculoskeletal Disorders Therapeutics Market Size by Type
6.2.1 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2027)
6.3 North America Musculoskeletal Disorders Therapeutics Market Size by Application
6.3.1 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2027)
6.4 North America Musculoskeletal Disorders Therapeutics Market Size by Country
6.4.1 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Musculoskeletal Disorders Therapeutics Market Size (2016-2027)
7.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Type
7.2.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2027)
7.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Application
7.3.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2027)
7.4 Europe Musculoskeletal Disorders Therapeutics Market Size by Country
7.4.1 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type
8.2.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application
8.3.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region
8.4.1 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Musculoskeletal Disorders Therapeutics Market Size (2016-2027)
9.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type
9.2.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application
9.3.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country
9.4.1 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type
10.2.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application
10.3.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country
10.4.1 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AbbVie
11.1.1 AbbVie Company Details
11.1.2 AbbVie Business Overview
11.1.3 AbbVie Musculoskeletal Disorders Therapeutics Introduction
11.1.4 AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.1.5 AbbVie Recent Development
11.2 Johnson & Johnson
11.2.1 Johnson & Johnson Company Details
11.2.2 Johnson & Johnson Business Overview
11.2.3 Johnson & Johnson Musculoskeletal Disorders Therapeutics Introduction
11.2.4 Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.2.5 Johnson & Johnson Recent Development
11.3 Amgen
11.3.1 Amgen Company Details
11.3.2 Amgen Business Overview
11.3.3 Amgen Musculoskeletal Disorders Therapeutics Introduction
11.3.4 Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.3.5 Amgen Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Details
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Musculoskeletal Disorders Therapeutics Introduction
11.4.4 Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.4.5 Pfizer Recent Development
11.5 F. Hoffmann-La Roche
11.5.1 F. Hoffmann-La Roche Company Details
11.5.2 F. Hoffmann-La Roche Business Overview
11.5.3 F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Introduction
11.5.4 F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.5.5 F. Hoffmann-La Roche Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Details
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Musculoskeletal Disorders Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.6.5 Eli Lilly Recent Development
11.7 Merck
11.7.1 Merck Company Details
11.7.2 Merck Business Overview
11.7.3 Merck Musculoskeletal Disorders Therapeutics Introduction
11.7.4 Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.7.5 Merck Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis Musculoskeletal Disorders Therapeutics Introduction
11.8.4 Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.8.5 Novartis Recent Development
11.9 AstraZeneca
11.9.1 AstraZeneca Company Details
11.9.2 AstraZeneca Business Overview
11.9.3 AstraZeneca Musculoskeletal Disorders Therapeutics Introduction
11.9.4 AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.9.5 AstraZeneca Recent Development
11.10 Astellas
11.10.1 Astellas Company Details
11.10.2 Astellas Business Overview
11.10.3 Astellas Musculoskeletal Disorders Therapeutics Introduction
11.10.4 Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.10.5 Astellas Recent Development
11.11 AB Sciences
11.11.1 AB Sciences Company Details
11.11.2 AB Sciences Business Overview
11.11.3 AB Sciences Musculoskeletal Disorders Therapeutics Introduction
11.11.4 AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.11.5 AB Sciences Recent Development
11.12 3SBio
11.12.1 3SBio Company Details
11.12.2 3SBio Business Overview
11.12.3 3SBio Musculoskeletal Disorders Therapeutics Introduction
11.12.4 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.12.5 3SBio Recent Development
11.13 Samsung Bioepis
11.13.1 Samsung Bioepis Company Details
11.13.2 Samsung Bioepis Business Overview
11.13.3 Samsung Bioepis Musculoskeletal Disorders Therapeutics Introduction
11.13.4 Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.13.5 Samsung Bioepis Recent Development
11.14 Sanofi
11.14.1 Sanofi Company Details
11.14.2 Sanofi Business Overview
11.14.3 Sanofi Musculoskeletal Disorders Therapeutics Introduction
11.14.4 Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.14.5 Sanofi Recent Development
11.15 Taisho Pharmaceutical
11.15.1 Taisho Pharmaceutical Company Details
11.15.2 Taisho Pharmaceutical Business Overview
11.15.3 Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Introduction
11.15.4 Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.15.5 Taisho Pharmaceutical Recent Development
11.16 Takeda
11.16.1 Takeda Company Details
11.16.2 Takeda Business Overview
11.16.3 Takeda Musculoskeletal Disorders Therapeutics Introduction
11.16.4 Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.16.5 Takeda Recent Development
11.17 Zosano Pharma
11.17.1 Zosano Pharma Company Details
11.17.2 Zosano Pharma Business Overview
11.17.3 Zosano Pharma Musculoskeletal Disorders Therapeutics Introduction
11.17.4 Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.17.5 Zosano Pharma Recent Development
11.18 LG Life Sciences
11.18.1 LG Life Sciences Company Details
11.18.2 LG Life Sciences Business Overview
11.18.3 LG Life Sciences Musculoskeletal Disorders Therapeutics Introduction
11.18.4 LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021)
11.18.5 LG Life Sciences Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Musculoskeletal Disorders Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Biologics
Table 3. Key Players of Small Molecules
Table 4. Global Musculoskeletal Disorders Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Musculoskeletal Disorders Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Musculoskeletal Disorders Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Musculoskeletal Disorders Therapeutics Market Share by Regions (2016-2021)
Table 8. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Musculoskeletal Disorders Therapeutics Market Share by Regions (2022-2027)
Table 10. Musculoskeletal Disorders Therapeutics Market Trends
Table 11. Musculoskeletal Disorders Therapeutics Market Drivers
Table 12. Musculoskeletal Disorders Therapeutics Market Challenges
Table 13. Musculoskeletal Disorders Therapeutics Market Restraints
Table 14. Global Musculoskeletal Disorders Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Musculoskeletal Disorders Therapeutics Market Share by Players (2016-2021)
Table 16. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2020)
Table 17. Ranking of Global Top Musculoskeletal Disorders Therapeutics Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Musculoskeletal Disorders Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Musculoskeletal Disorders Therapeutics Product Solution and Service
Table 21. Date of Enter into Musculoskeletal Disorders Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Table 25. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Musculoskeletal Disorders Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2016-2021)
Table 29. Global Musculoskeletal Disorders Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 61. AbbVie Company Details
Table 62. AbbVie Business Overview
Table 63. AbbVie Musculoskeletal Disorders Therapeutics Product
Table 64. AbbVie Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 65. AbbVie Recent Development
Table 66. Johnson & Johnson Company Details
Table 67. Johnson & Johnson Business Overview
Table 68. Johnson & Johnson Musculoskeletal Disorders Therapeutics Product
Table 69. Johnson & Johnson Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 70. Johnson & Johnson Recent Development
Table 71. Amgen Company Details
Table 72. Amgen Business Overview
Table 73. Amgen Musculoskeletal Disorders Therapeutics Product
Table 74. Amgen Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 75. Amgen Recent Development
Table 76. Pfizer Company Details
Table 77. Pfizer Business Overview
Table 78. Pfizer Musculoskeletal Disorders Therapeutics Product
Table 79. Pfizer Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 80. Pfizer Recent Development
Table 81. F. Hoffmann-La Roche Company Details
Table 82. F. Hoffmann-La Roche Business Overview
Table 83. F. Hoffmann-La Roche Musculoskeletal Disorders Therapeutics Product
Table 84. F. Hoffmann-La Roche Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 85. F. Hoffmann-La Roche Recent Development
Table 86. Eli Lilly Company Details
Table 87. Eli Lilly Business Overview
Table 88. Eli Lilly Musculoskeletal Disorders Therapeutics Product
Table 89. Eli Lilly Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 90. Eli Lilly Recent Development
Table 91. Merck Company Details
Table 92. Merck Business Overview
Table 93. Merck Musculoskeletal Disorders Therapeutics Product
Table 94. Merck Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 95. Merck Recent Development
Table 96. Novartis Company Details
Table 97. Novartis Business Overview
Table 98. Novartis Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Novartis Recent Development
Table 100. AstraZeneca Company Details
Table 101. AstraZeneca Business Overview
Table 102. AstraZeneca Musculoskeletal Disorders Therapeutics Product
Table 103. AstraZeneca Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 104. AstraZeneca Recent Development
Table 105. Astellas Company Details
Table 106. Astellas Business Overview
Table 107. Astellas Musculoskeletal Disorders Therapeutics Product
Table 108. Astellas Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 109. Astellas Recent Development
Table 110. AB Sciences Company Details
Table 111. AB Sciences Business Overview
Table 112. AB Sciences Musculoskeletal Disorders Therapeutics Product
Table 113. AB Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 114. AB Sciences Recent Development
Table 115. 3SBio Company Details
Table 116. 3SBio Business Overview
Table 117. 3SBio Musculoskeletal Disorders Therapeutics Product
Table 118. 3SBio Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 119. 3SBio Recent Development
Table 120. Samsung Bioepis Company Details
Table 121. Samsung Bioepis Business Overview
Table 122. Samsung Bioepis Musculoskeletal Disorders Therapeutics Product
Table 123. Samsung Bioepis Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 124. Samsung Bioepis Recent Development
Table 125. Sanofi Company Details
Table 126. Sanofi Business Overview
Table 127. Sanofi Musculoskeletal Disorders Therapeutics Product
Table 128. Sanofi Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 129. Sanofi Recent Development
Table 130. Taisho Pharmaceutical Company Details
Table 131. Taisho Pharmaceutical Business Overview
Table 132. Taisho Pharmaceutical Musculoskeletal Disorders Therapeutics Product
Table 133. Taisho Pharmaceutical Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 134. Taisho Pharmaceutical Recent Development
Table 135. Takeda Company Details
Table 136. Takeda Business Overview
Table 137. Takeda Musculoskeletal Disorders Therapeutics Product
Table 138. Takeda Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 139. Takeda Recent Development
Table 140. Zosano Pharma Company Details
Table 141. Zosano Pharma Business Overview
Table 142. Zosano Pharma Musculoskeletal Disorders Therapeutics Product
Table 143. Zosano Pharma Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 144. Zosano Pharma Recent Development
Table 145. LG Life Sciences Company Details
Table 146. LG Life Sciences Business Overview
Table 147. LG Life Sciences Musculoskeletal Disorders Therapeutics Product
Table 148. LG Life Sciences Revenue in Musculoskeletal Disorders Therapeutics Business (2016-2021) & (US$ Million)
Table 149. LG Life Sciences Recent Development
Table 150. Research Programs/Design for This Report
Table 151. Key Data Information from Secondary Sources
Table 152. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Musculoskeletal Disorders Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Biologics Features
Figure 3. Small Molecules Features
Figure 4. Global Musculoskeletal Disorders Therapeutics Market Share by Application: 2020 VS 2027
Figure 5. Osteoarthritis Case Studies
Figure 6. Osteoporosis Case Studies
Figure 7. Psoriatic Arthritis Case Studies
Figure 8. Ankylosing Spondylitis Case Studies
Figure 9. Fibromyalgia Case Studies
Figure 10. Musculoskeletal Disorders Therapeutics Report Years Considered
Figure 11. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Musculoskeletal Disorders Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Musculoskeletal Disorders Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Musculoskeletal Disorders Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Musculoskeletal Disorders Therapeutics Market Share by Players in 2020
Figure 16. Global Top Musculoskeletal Disorders Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Musculoskeletal Disorders Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Musculoskeletal Disorders Therapeutics Revenue in 2020
Figure 18. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Musculoskeletal Disorders Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Musculoskeletal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Musculoskeletal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Musculoskeletal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Musculoskeletal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Musculoskeletal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Musculoskeletal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Musculoskeletal Disorders Therapeutics Market Share by Region (2016-2027)
Figure 40. China Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Musculoskeletal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Musculoskeletal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Musculoskeletal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Musculoskeletal Disorders Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Musculoskeletal Disorders Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AbbVie Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 60. Johnson & Johnson Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 61. Amgen Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 62. Pfizer Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 63. F. Hoffmann-La Roche Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 64. Eli Lilly Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 65. Merck Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 66. Novartis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 67. AstraZeneca Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 68. Astellas Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 69. AB Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 70. 3SBio Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 71. Samsung Bioepis Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 72. Sanofi Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 73. Taisho Pharmaceutical Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 74. Takeda Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 75. Zosano Pharma Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 76. LG Life Sciences Revenue Growth Rate in Musculoskeletal Disorders Therapeutics Business (2016-2021)
Figure 77. Bottom-up and Top-down Approaches for This Report
Figure 78. Data Triangulation
Figure 79. Key Executives Interviewed

---